Cargando…

Emergence of Myasthenia Gravis with Myositis in a Patient Treated with Pembrolizumab for Thymic Cancer

Detalles Bibliográficos
Autores principales:	Huh, So-Young, Shin, Seong-Hoon, Kim, Meyung Kug, Lee, So-Young, Son, Ki Hun, Shin, Ha Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Neurological Association 2018
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765246/ https://www.ncbi.nlm.nih.gov/pubmed/29629546 http://dx.doi.org/10.3988/jcn.2018.14.1.115

Ejemplares similares

Pembrolizumab‐induced myasthenia gravis with myositis in a patient with lung cancer
por: Hibino, Makoto, et al.
Publicado: (2018)

Initial Repetitive Nerve Stimulation Test Predicts Conversion of Ocular Myasthenia Gravis to Generalized Myasthenia Gravis
por: Kim, Ki Hoon, et al.
Publicado: (2021)

Pembrolizumab‐induced myasthenia gravis with myositis and presumable myocarditis in a patient with bladder cancer
por: Todo, Maki, et al.
Publicado: (2019)

Pathologic Finding of Thymic Carcinoma Accompanied by Myasthenia Gravis
por: Kim, Se Hoon, et al.
Publicado: (2015)

Pembrolizumab-induced myasthenia gravis-like disorder, ocular myositis, and hepatitis: a case report
por: Tian, Chia-Yi, et al.
Publicado: (2021)

Editorial Comment to Pembrolizumab‐induced myasthenia gravis with myositis and presumable myocarditis in a patient with bladder cancer
por: Tomisaki, Ikko
Publicado: (2019)

The Epidemiology of Myasthenia Gravis in Korea
por: Lee, Hyung Seok, et al.
Publicado: (2016)

Whole-Genome Analysis in Korean Patients with Autoimmune Myasthenia Gravis
por: Na, Sang-Jun, et al.
Publicado: (2014)

Pembrolizumab-Induced Myasthenia Gravis and Myositis: Literature Review on Neurological Toxicities of Programmed Death Protein 1 Inhibitors
por: Schwab, Alfred, et al.
Publicado: (2022)

A Case of Pembrolizumab-Induced Myasthenia Gravis
por: Kosick, Thomas I, et al.
Publicado: (2023)

Localized Thymic Amyloidosis Presenting with Myasthenia Gravis: Case Report
por: Son, Seung-Myoung, et al.
Publicado: (2014)

Granulomatous Myositis Associated with Myasthenia Gravis: A Rare Case
por: Iqbal, Shumaila M, et al.
Publicado: (2019)

Nivolumab-Induced Myasthenia Gravis Concomitant With Myocarditis, Myositis, and Hepatitis
por: Bawek, Sawyer J, et al.
Publicado: (2021)

Long-Term Safety and Efficacy of Tacrolimus in Myasthenia Gravis
por: Kim, Yool-hee, et al.
Publicado: (2019)

Thymic carcinoma with myasthenia gravis: Two case reports
por: Kurihara, Nobuyasu, et al.
Publicado: (2016)

Somatic mutations of thymic epithelial tumors with myasthenia gravis
por: Pardini, Eleonora, et al.
Publicado: (2023)

Anti-titin antibody is associated with more frequent hospitalization to manage thymoma-associated myasthenia gravis
por: Kim, Ki Hoon, et al.
Publicado: (2022)

Pembrolizumab-induced Myasthenia Gravis Relapse after Immunosuppressive Therapy
por: Oshima, Yuki, et al.
Publicado: (2022)

Transsternal Maximal Thymectomy is Effective for Extirpation of Cervical Ectopic Thymic Tissue in the Treatment of Myasthenia Gravis
por: Lee, Chang Young, et al.
Publicado: (2008)

Durvalumab-induced myocarditis, myositis, and myasthenia gravis: a case report
por: Cham, Jason, et al.
Publicado: (2021)

FK506 attenuates thymic output in patients with myasthenia gravis
por: Mitsui, Takao, et al.
Publicado: (2013)

Myasthenia Gravis Related to Thymic Carcinoma: A Case Study
por: Lopes, Daniel Thomas Pereira, et al.
Publicado: (2020)

Pembrolizumab treatment of metastatic urothelial cancer without exacerbating myasthenia gravis
por: Ishii, Akiko, et al.
Publicado: (2020)

Pembrolizumab-Induced Myasthenia Gravis and Peripheral Neuropathy: A Case Series
por: McCormack, Sean M, et al.
Publicado: (2023)

Pembrolizumab-Induced Myasthenia Gravis: A Case Report and Review of the Literature
por: Eglenen Polat, Buse, et al.
Publicado: (2023)

Ictal Neuropsychological Assessment in a Patient with Transient Global Amnesia
por: Na, Ju-Young, et al.
Publicado: (2013)

Myositis associated to COVID-19 mimics an acute exacerbation in myasthenia gravis patient
por: De Martino, Antonio, et al.
Publicado: (2021)

Myocarditis-myositis-myasthenia gravis overlap syndrome depending on immune checkpoint inhibitor
por: Ünlütürk, Zeynep, et al.
Publicado: (2023)

Mogamulizumab-Associated Myositis With and Without Myasthenia Gravis and/or Myocarditis in Patients With T-Cell Lymphoma
por: Virgen, Cesar A, et al.
Publicado: (2023)

Comparative Analysis of Thymic and Blood Treg in Myasthenia Gravis: Thymic Epithelial Cells Contribute to Thymic Immunoregulatory Defects
por: Truffault, Frédérique, et al.
Publicado: (2020)

Updates in CT characterization of thymic epithelial tumors in patients with myasthenia gravis
por: Popa, GA, et al.
Publicado: (2012)

Blocking interleukin-23 ameliorates neuromuscular and thymic defects in myasthenia gravis
por: Villegas, José A., et al.
Publicado: (2023)

The Impacts of Influenza Infection and Vaccination on Exacerbation of Myasthenia Gravis
por: Seok, Hung Youl, et al.
Publicado: (2017)

Factors affecting the intention of COVID-19 vaccination in Korean patients with myasthenia gravis: A survey-based study
por: Kim, Sooyoung, et al.
Publicado: (2022)

Repetitive Nerve Stimulation in MuSK-Antibody-Positive Myasthenia Gravis
por: Kim, Seung Woo, et al.
Publicado: (2017)

Pembrolizumab-induced Ocular Myasthenia Gravis with Anti-titin Antibody and Necrotizing Myopathy
por: Onda, Asako, et al.
Publicado: (2019)

Cytometric cell-based assays for anti-striational antibodies in myasthenia gravis with myositis and/or myocarditis
por: Kufukihara, Kenji, et al.
Publicado: (2019)

Camrelizumab-Related Myocarditis and Myositis With Myasthenia Gravis: A Case Report and Literature Review
por: Bai, Jing, et al.
Publicado: (2022)

Status Epilepticus as an Unusual Manifestation of Heat Stroke
por: Lee, Won Gu, et al.
Publicado: (2017)

Pembrolizumab-Associated Seronegative Myasthenia Gravis in a Patient With Metastatic Renal Cell Carcinoma
por: Pandya, Shaunak K, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_urla1nhnike9ccqsg4mmmmd20f